DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
01 6Dr. Reddy's Laboratories
02 1Pharmathen SA
03 4Accord healthcare
04 1Activo Health
05 1Akorn Pharmaceuticals
06 1Altan Pharma
07 1Aurobindo Pharma Limited
08 1Austell Laboratories
09 2Avet Pharmaceuticals
10 2Avyxa
11 1Baxter Healthcare Corporation
12 1Biem Ilac San. ve Tic. A.S
13 1Chartwell Pharmaceuticals llc
14 1Cipla
15 2Eurolab
16 4Farbe Firma
17 1Farmatek
18 3Fresenius Kabi AB Brunna
19 3Fresenius Kabi USA
20 1Fresenius SE & Co. KGaA
21 2Hangzhou Jiuyuan Gene Engineering
22 19Helsinn Advanced Synthesis
23 1Hetero Drugs
24 1Hikma Pharmaceuticals
25 2Hospira, Inc.
26 1Jiangsu Hengrui Medicine
27 1Kalcex
28 2Knight Therapeutics
29 1MEDOCHEMIE LTD
30 1Macleods Pharmaceuticals Limited
31 2Medsurge Healthcare
32 1Meitheal Pharmaceuticals
33 1Novast Laboratories
34 1ORIFARM GROUP AS
35 1Pharmada Pharmaceuticals
36 1Polifarma
37 3Qilu Pharmaceutical
38 1Reig Jofre
39 2Sagent Pharmaceuticals
40 3Samyang Biopharmaceuticals
41 1Sandoz B2B
42 1Tecnimede
43 3Teva Pharmaceutical Industries
44 2Themis Medicare
45 2TherDose Pharma
46 1Viatris
47 1Yangtze River Pharmaceutical Group
01 1CAPSULE
02 2CAPSULE;ORAL
03 2Capsule
04 1Capsule, hard
05 2Capsule, soft
06 1Concentrate For Solution For Infusion
07 2Hard Capsule
08 8INJ
09 1INJECTABLE;INJECTION
10 25INJECTABLE;INTRAVENOUS
11 1IV Injection Solution
12 9Injectable Solution
13 1Injectable Solution In Pre-Filled Syringe
14 14Injection
15 3Injection fluid, resolution
16 2Kapsel, hard
17 3Liquid Injection
18 1Netupitant+Palonosetron 0,5+300Mg 1 Combined Oral Use
19 1POWDER;INTRAVENOUS
20 1Palonosetron 250Mcg 5Ml 1 Units Parenteral Use
21 2Powder For Concentrate For Solution For Infusion
22 1SOLUTION
23 5SOLUTION;INTRAVENOUS
24 1Solution for I.V. Injection
25 1Solution for IV Injection
26 1Solution for Injection
27 4Blank
01 3Approved
02 8Authorized
03 3Cancelled
04 14DISCN
05 7Generic
06 2Lead Market Dossiers- Filed
07 2Originator
08 2Prescription
09 19RX
10 1USA
11 35Blank
01 4AKYNZEO
02 4ALOXI
03 10Akynzeo
04 5Aloxi
05 1Bevativa
06 1Ferant
07 1Hetnoset
08 1Kemoprev IV
09 1Onicit
10 2PALIBOUT
11 3PALONOSETRON
12 1PALONOSETRON 0.05mg/ml FRESENIUS
13 1PALONOSETRON 0.25 TEVA
14 26PALONOSETRON HYDROCHLORIDE
15 2PALONOSETRON Medsurge
16 2POSFREA
17 1Palcita
18 2Palonosetron Accord
19 1Palonosetron Altan
20 2Palonosetron Dr.Reddy's
21 3Palonosetron Fresenius Kabi
22 1Palonosetron Kalceks
23 1Palonosetron Qilu
24 1Palonosetron Sala
25 1Paloxitron
26 1Palton
27 1Themiset 250
28 1Themiset 75
29 1Votron
30 14Blank
01 4Australia
02 2Canada
03 4China
04 1Greece
05 10India
06 2Italy
07 8Norway
08 1Portugal
09 9South Africa
10 3South Korea
11 11Spain
12 3Sweden
13 4Turkey
14 34USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : DISCN
Registration Country : USA
Brand Name : PALONOSETRON HYDROCHLORIDE
Dosage Form : INJECTABLE;INTRAVENOUS
Dosage Strength : EQ 0.075MG BASE/1.5ML (EQ 0.05MG BASE/ML)
Packaging :
Approval Date : 2016-04-21
Application Number : 201533
Regulatory Info : DISCN
Registration Country : USA
Pharmathen provides life cycle Management solutions for branded pharma, as well as to develop & establish new technology platforms.
Regulatory Info : USA
Registration Country : Greece
Brand Name :
Dosage Form : Hard Capsule
Dosage Strength : 300; 0.5
Packaging :
Approval Date :
Application Number :
Regulatory Info : USA
Registration Country : Greece
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : RX
Registration Country : USA
Brand Name : PALONOSETRON HYDROCHLORIDE
Dosage Form : INJECTABLE;INTRAVENOUS
Dosage Strength : EQ 0.25MG BASE/5ML (EQ 0.05MG BASE/ML)
Packaging :
Approval Date : 2016-04-21
Application Number : 201533
Regulatory Info : RX
Registration Country : USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Brand Name :
Dosage Form : Injection
Dosage Strength : 0.075MG/5ML
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Brand Name :
Dosage Form : Injection
Dosage Strength : 0.25MG/5ML
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info :
Registration Country : Australia
Brand Name : Palonosetron Dr.Reddy's
Dosage Form :
Dosage Strength :
Packaging : 1
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Australia
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info :
Registration Country : Australia
Brand Name : Palonosetron Dr.Reddy's
Dosage Form :
Dosage Strength :
Packaging : 1
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Australia
Regulatory Info : DISCN
Registration Country : USA
Brand Name : PALONOSETRON HYDROCHLORIDE
Dosage Form : INJECTABLE;INTRAVENOUS
Dosage Strength : EQ 0.25MG BASE/5ML (EQ 0.05MG BASE/ML)
Packaging :
Approval Date : 2021-03-15
Application Number : 204615
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : PALONOSETRON HYDROCHLORIDE
Dosage Form : INJECTABLE;INTRAVENOUS
Dosage Strength : EQ 0.25MG BASE/5ML (EQ 0.05MG BASE/ML)
Packaging :
Approval Date : 2018-11-06
Application Number : 204702
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : PALONOSETRON HYDROCHLORIDE
Dosage Form : INJECTABLE;INTRAVENOUS
Dosage Strength : EQ 0.075MG BASE/1.5ML (EQ 0.05MG BASE/ML)
Packaging :
Approval Date : 2021-06-29
Application Number : 202951
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : PALONOSETRON HYDROCHLORIDE
Dosage Form : INJECTABLE;INTRAVENOUS
Dosage Strength : EQ 0.25MG BASE/5ML (EQ 0.05MG BASE/ML)
Packaging :
Approval Date : 2021-06-29
Application Number : 202951
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : POSFREA
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : EQ 0.075MG BASE/1.5ML (EQ 0.05MG BASE/ML)
Packaging :
Approval Date : 2016-03-01
Application Number : 203050
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : POSFREA
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : EQ 0.25MG BASE/5ML (EQ 0.05MG BASE/ML)
Packaging :
Approval Date : 2016-03-01
Application Number : 203050
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : ALOXI
Dosage Form : INJECTABLE;INTRAVENOUS
Dosage Strength : EQ 0.25MG BASE/5ML (EQ 0.05MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 2003-07-25
Application Number : 21372
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : ALOXI
Dosage Form : INJECTABLE;INTRAVENOUS
Dosage Strength : EQ 0.075MG BASE/1.5ML (EQ 0.05MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 2008-02-29
Application Number : 21372
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : ALOXI
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 0.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 2008-08-22
Application Number : 22233
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : PALONOSETRON HYDROCHLORIDE
Dosage Form : INJECTABLE;INTRAVENOUS
Dosage Strength : EQ 0.25MG BASE/5ML (EQ 0.05MG BASE/ML)
Packaging :
Approval Date : 2018-09-19
Application Number : 204289
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : PALONOSETRON HYDROCHLORIDE
Dosage Form : INJECTABLE;INTRAVENOUS
Dosage Strength : EQ 0.25MG BASE/5ML (EQ 0.05MG BASE/ML)
Packaging :
Approval Date : 2015-10-13
Application Number : 202521
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : PALONOSETRON HYDROCHLORIDE
Dosage Form : INJECTABLE;INTRAVENOUS
Dosage Strength : EQ 0.25MG BASE/5ML (EQ 0.05MG BASE/ML)
Packaging :
Approval Date : 2018-03-23
Application Number : 90713
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : PALONOSETRON HYDROCHLORIDE
Dosage Form : INJECTABLE;INTRAVENOUS
Dosage Strength : EQ 0.075MG BASE/1.5ML (EQ 0.05MG BASE/ML)
Packaging :
Approval Date : 2018-03-23
Application Number : 90713
Regulatory Info : DISCN
Registration Country : USA
